BioAtla LLC

Jun 28, 2019

BioAtla Appoints Eric Sievers, M.D., As Chief Medical Officer

Sep 10, 2018

BioAtla Appoints Scott Smith As President

Jul 24, 2018

BioAtla Appoints Lawrence Fong, M.D. As Scientific Advisor

Jun 28, 2018

BioAtla Announces First Patient Treated In Phase1/2 BA3021-001 Clinical Trial For CAB-ROR2-ADC Therapeutic

Feb 28, 2018

BioAtla Announces First Patient Treated In Phase1/2 BA3011-001 Clinical Trial For CAB-AXL-ADC Therapeutic

Jan 24, 2018

Bioatla Announces FDA Clearance Of Investigational New Drug Application For CAB-AXL-ADC Therapeutic

Jan 08, 2018

Clinical Trial Utilizing BioAtla's Conditionally Active Biologics In CAR-T Candidates For Solid Tumors To Be Initiated In China

Nov 16, 2017

BioAtla Appoints James Allison, Ph.D. And Padmanee Sharma, M.D., Ph.D. As Scientific Advisors